CD36, CD36 molecule, 948

N. diseases: 351; N. variants: 61
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Circulating Soluble CD36 is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects. 31109109 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE We analyzed the mRNA expression of SRs (LOX-1, MSR1, CXCL16, CD36 and CL-P1) and macrophage markers (CD68, CD11c and CD206) in EAT from 45 patients with IHD (23 with type 2 diabetes mellitus (T2DM) and 22 without T2DM) and 23 controls without IHD or T2DM. 30894181 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Overall, our data do not support a major contribution of CD36 rare coding mutations to T2D and its cardio-metabolic complications in the French population. 31748580 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE A positive correlation between exercise-induced changes in skeletal muscle CD36 mRNA expression and concentrations of SkMVs carrying CD36 was found in T2DM only. 30933285 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE BACKGROUND CD36 plays a critical role in many sterile inflammatory diseases, including type 2 diabetes mellitus, atherosclerosis, and primary nephrotic syndrome. 30258045 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We observed remarkable suppression of foam cell formation by teneligliptin treatment <i>ex vivo</i> in macrophages isolated from diabetic <i>db/db</i> mice (32%) and T2D patients (38%); this effect was accompanied by a reduction of CD36 (<i>db/db</i> mice, 43%; T2D patients, 46%) and acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) gene expression levels (<i>db/db</i> mice, 47%; T2D patients, 45%). 30627161 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE CD36 genotypes were not associated with the progression to T2DM independently. 29572193 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE In the past decade, microvesicles (MVs) and CD36 have increasingly been considered as possible biomarkers for obesity, the metabolic syndrome (MetSy), type 2 diabetes mellitus (T2DM). 30386406 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE In summary, we identified a CD36-dependent FA-sensing pathway that plays an important role in negative feedback regulation of insulin activation and may open up strategies for preventing or managing type 2 diabetes mellitus. 29269414 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Potential human relevance is suggested by genome-wide analysis and RNA sequencing data that associate genetically determined low muscle CD36 expression to incidence of type 2 diabetes. 29748289 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE The aim of this study is to determine the correlations of plasma soluble CD36 concentrations with carotid intima-media thickness (IMT) and cognitive function in patients with type 2 diabetes. 28883843 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Eleven SNPs in the CD36 gene and their association with 100 each of control subjects and T2DM patients were investigated in the present study. 25565374 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Moreover, CD36 expression was increased in gingival fibroblasts of high-fat diet-induced T2D model mice, compared with gingival fibroblasts of mice fed a normal diet. 25921577 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE High affinity FA binding to CD36 and the effects of each FA on oxLDL uptake have important implications for protein conformation, binding of other ligands, functional properties of CD36, and high plasma FA levels in obesity and type 2 diabetes. 25555908 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE The present study evaluated the effect of genetic polymorphisms of the CD36 gene on the risk of developing T2DM. 23844572 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Circulating CD36 is reduced in HNF1A-MODY carriers. 24069322 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Patients with T2DM also exhibited increased monocyte activation markers (CD11b and CD36) and proinflammatory signals downstream of NOD (RIPK2 and NFκB) along with the increased circulatory levels of TNF-α and IL-6. 24018334 2013
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Therefore, the association of human CD36 gene mutation to T2DM needs investigation. 21808142 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Therefore, we investigated whether genetic variation within the CD36 gene locus affects insulin resistance in a well-phenotyped cohort of white European subjects at increased risk for type 2 diabetes. 20966915 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE An attempt has been made to review the CD36 macrophage receptor and related molecules in association with T2DM. 21262584 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Genetic variation at the CD36 loci have been associated with obesity and lipid components of the metabolic syndrome, with risk of heart disease and type 2 diabetes. 21250778 2011
Diabetes Mellitus, Non-Insulin-Dependent
0.300 AlteredExpression disease BEFREE Increased CD36 expression signals monocyte activation among patients with type 2 diabetes. 20551015 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease RGD The aim of this work was to investigate advanced glycation end products (AGE)-induced CD36 expression and its regulation by insulin in aortic vascular smooth muscle cells (VSMCs) from Goto-Kakisaki (GK) rats, a non-obese insulin model of both insulin resistance and type 2 diabetes. 17127041 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We conclude that CD36 variants may impact MetS pathophysiology and HDL metabolism, both predictors of the risk of heart disease and type 2 diabetes. 18305138 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE This is the first study to show a direct association of a CD36 snp with T2DM. 16911630 2006